MEDIFAST INC — Director's Dealing 2022

Nov 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2022-11-08

Reporting Person: Hoer Michael A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-08	Common Stock	P	10.087	$106.93	Acquired	5147.768	Direct

Footnotes

F1: The shares were acquired pursuant to a dividend reinvestment feature in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The shares accrued when and as dividends were paid on Medifast common stock.